Portfolio Strategies Channel Bullish Outlook for Pharma Prices Could Lift This ETF By Tom LydonFebruary 6, 2023
Beyond Basic Beta Channel Growth, Innovation Could Fuel Pharma ETF Rebound By Tom LydonDecember 21, 2022
Beyond Basic Beta Channel Pharma Stocks, ETFs Can Deal With Drug Pricing Legislation By Tom LydonJuly 27, 2022
Dual Impact Channel This Pharmaceutical Company Is Growing — Here’s How to Invest By Karrie GordonMay 6, 2022
Beyond Basic Beta Channel Pharmaceuticals Stocks, ETFs Could Have Power Beyond 2022 By Tom LydonFebruary 4, 2022
Beyond Basic Beta Channel Pharma Could Be Place to Be for Healthcare Winners, Value By Tom LydonJanuary 7, 2022
Beyond Basic Beta Channel Write a Prescription for Pharma Dividends With PPH By Tom LydonDecember 9, 2021
Beyond Basic Beta Channel Omicron Variant Could Be Potent for Pharma Stocks, ETFs By Tom LydonDecember 2, 2021
ETF Education channel Economics, Patents Critical for Pharmaceuticals Innovation, Equity Prices By Tom LydonNovember 15, 2021
Beyond Basic Beta Channel PPH Pertinent as Some Cheap Pharma Stocks Offer Big Dividend Growth By Tom LydonNovember 9, 2021
ETF Education channel Blue-Chip Pharmaceuticals Stocks Contend With Political Headwinds By Tom LydonSeptember 21, 2021